Best TWAS P=6.05e-39 · Best GWAS P=1.47e-28 conditioned to 1
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | FURIN | 0.12 | 0.14 | lasso | 2 | 0.13 | 1.2e-15 | -7.2 | 7.2 | 6.7e-13 | 0.62 | 0.99 | 0.01 | TRUE |
2 | GTEx | Adipose Visceral Omentum | FES | 0.21 | 0.09 | lasso | 5 | 0.05 | 1.3e-03 | 11.1 | -11.0 | 6.5e-28 | -0.99 | 0.00 | 0.99 | FALSE |
3 | GTEx | Artery Tibial | FES | 0.16 | 0.04 | lasso | 5 | 0.05 | 4.8e-05 | 10.2 | -11.3 | 2.2e-29 | -0.89 | 0.01 | 0.99 | FALSE |
4 | GTEx | Breast Mammary Tissue (Male) | RCCD1 | 0.33 | -0.01 | enet | 28 | 0.07 | 1.3e-02 | 11.1 | 5.4 | 5.5e-08 | 0.28 | 0.03 | 0.48 | FALSE |
5 | GTEx | Cells Transformed fibroblasts | FES | 0.28 | 0.17 | enet | 21 | 0.20 | 2.8e-15 | 11.1 | -11.9 | 6.9e-33 | -0.92 | 0.00 | 1.00 | FALSE |
6 | GTEx | Lung | FES | 0.24 | 0.07 | lasso | 6 | 0.05 | 5.1e-05 | 10.2 | -11.8 | 2.6e-32 | -0.90 | 0.01 | 0.99 | FALSE |
7 | GTEx | Skin Sun Exposed Lower leg | FES | 0.09 | 0.04 | lasso | 5 | 0.04 | 1.4e-04 | 11.1 | -9.6 | 5.7e-22 | -0.91 | 0.00 | 0.98 | FALSE |
8 | GTEx | Thyroid | FES | 0.33 | 0.19 | lasso | 6 | 0.18 | 4.3e-14 | 10.7 | -10.7 | 8.9e-27 | -0.95 | 0.02 | 0.98 | TRUE |
9 | METSIM | Adipose | FES | 0.08 | 0.06 | lasso | 3 | 0.05 | 6.8e-08 | 10.2 | -10.5 | 5.4e-26 | -0.88 | 0.15 | 0.85 | FALSE |
10 | YFS | Blood | FES | 0.31 | 0.11 | enet | 77 | 0.22 | 1.2e-68 | 11.1 | -10.6 | 2.9e-26 | -0.61 | 0.00 | 1.00 | FALSE |
11 | YFS | Blood | FURIN | 0.11 | 0.03 | enet | 37 | 0.06 | 8.3e-19 | -7.2 | -8.0 | 1.3e-15 | -0.48 | 0.13 | 0.87 | FALSE |
12 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | FES | 0.06 | 0.05 | blup | 46 | 0.06 | 1.9e-05 | 10.9 | -10.2 | 2.5e-24 | -0.74 | 0.01 | 0.99 | FALSE |
13 | The Cancer Genome Atlas | Breast Invasive Carcinoma | FES | 0.06 | 0.05 | blup | 46 | 0.07 | 7.4e-14 | 11.1 | -13.1 | 6.1e-39 | -0.88 | 0.00 | 1.00 | TRUE |
14 | The Cancer Genome Atlas | Cervical Squamous Cell Carcinoma | FES | 0.06 | 0.02 | blup | 46 | 0.02 | 2.4e-02 | 11.1 | -11.0 | 3.7e-28 | -0.81 | 0.00 | 0.87 | FALSE |
15 | The Cancer Genome Atlas | Colon Adenocarcinoma | FES | 0.08 | 0.07 | blup | 46 | 0.06 | 3.4e-04 | 10.5 | -11.2 | 3.7e-29 | -0.84 | 0.02 | 0.96 | FALSE |
16 | The Cancer Genome Atlas | Glioblastoma Multiforme | FES | 0.12 | 0.06 | enet | 6 | 0.06 | 5.7e-03 | 10.9 | -10.5 | 1.5e-25 | -0.80 | 0.01 | 0.89 | FALSE |
17 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | FES | 0.06 | 0.03 | blup | 46 | 0.05 | 5.6e-06 | 10.9 | -10.5 | 9.3e-26 | -0.78 | 0.01 | 0.99 | FALSE |
18 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | FES | 0.10 | 0.07 | enet | 5 | 0.05 | 2.8e-06 | 11.1 | -10.6 | 4.3e-26 | -0.70 | 0.01 | 0.99 | FALSE |
19 | The Cancer Genome Atlas | Lung Adenocarcinoma | FES | 0.05 | 0.04 | lasso | 2 | 0.04 | 2.2e-05 | 11.1 | -11.9 | 8.6e-33 | -0.95 | 0.00 | 1.00 | FALSE |
20 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | FES | 0.08 | 0.07 | enet | 7 | 0.08 | 4.2e-09 | 11.1 | -11.6 | 2.6e-31 | -0.93 | 0.00 | 1.00 | FALSE |
21 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | FES | 0.13 | 0.16 | lasso | 2 | 0.14 | 6.1e-10 | 11.1 | -11.0 | 2.2e-28 | -0.99 | 0.00 | 1.00 | FALSE |
22 | The Cancer Genome Atlas | Prostate Adenocarcinoma | FES | 0.12 | 0.09 | lasso | 5 | 0.08 | 4.1e-09 | 11.1 | -12.3 | 1.3e-34 | -0.95 | 0.00 | 1.00 | FALSE |
23 | The Cancer Genome Atlas | Stomach Adenocarcinoma | FES | 0.04 | 0.01 | blup | 46 | 0.02 | 1.7e-02 | 10.9 | -11.1 | 1.2e-28 | -0.75 | 0.01 | 0.61 | FALSE |
24 | The Cancer Genome Atlas | Testicular Germ Cell Tumors | FES | 0.32 | 0.26 | lasso | 2 | 0.25 | 2.0e-09 | 11.0 | -11.1 | 1.3e-28 | -0.96 | 0.00 | 1.00 | FALSE |
25 | The Cancer Genome Atlas | Thyroid Carcinoma | FES | 0.30 | 0.30 | lasso | 7 | 0.32 | 1.3e-31 | 11.0 | -12.2 | 5.6e-34 | -0.95 | 0.00 | 1.00 | FALSE |